ZBIO: Zenas BioPharma, Inc.
Performance
ZBIO -15.00%
Watchlist
Select an item
Summary
ZBIO at a glance
ZBIO returned -15.00% over the past year. Its worst drop in that year was -64.79%, smaller than 9% of stocks on Redstone, and its Sharpe ratio of 0.35 beats 43% of stocks on Redstone. It pays no dividends.
Current Drawdown
-33.82%
Rolling Volatility
65.74%
Actions
Metrics
Risk Indicators
Alpha26.10%
Beta0.72x
Sharpe0.35
Sortino0.45
Omega1.07
Calmar-0.23
Martin0.81
Profile
About ZBIO
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.9B
- Listed
- Sep 2024
- Employees
- 167
- Headquarters
- Waltham, MA
- Website
- zenasbio.com
Comparisons